TIEMANN INVESTMENT ADVISORS, LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1575151
MENLO PARK, CA
Position in BMY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$228,232
-$15,641 QoQ
Shares Held
3,961
-1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,053
of 2,506 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TIEMANN INVESTMENT ADVISORS, LLC holds $9,289,456 across 7 Drug Manufacturers - General names. BMY ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,451 | $2,654,240 | |
| 2 | LLY |
ELI LILLY & Co
|
2,149 | $2,577,575 | |
| 3 | ABBV |
AbbVie Inc.
|
9,227 | $2,321,882 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,492 | $834,222 | |
| 5 | AMGN |
Amgen Inc
|
1,119 | $405,212 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,122 | $268,093 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
3,961 | $228,232 |
All Filings in BMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $228,232 | 3,961 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $243,873 | 4,021 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $204,756 | 3,796 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $245,850 | 4,031 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $227,993 | 4,031 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $210,633 | 4,071 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $231,616 | 4,271 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $221,710 | 4,321 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $258,045 | 4,446 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $284,321 | 4,446 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $310,578 | 4,481 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $322,407 | 4,481 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $300,781 | 4,231 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $435,512 | 5,656 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $413,787 | 5,666 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $368,239 | 5,906 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $368,392 | 6,226 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $436,067 | 6,526 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $476,378 | 7,546 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $543,568 | 8,763 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $528,321 | 8,763 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $509,384 | 8,663 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $449,431 | 8,063 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||